Programmes Opioids Clinical Primer Ressources Recommendations for the use of slow-release oral morphine as opioid agonist therapy
Certains contenus peuvent être disponibles uniquement en anglais.
Recommendations for the use of slow-release oral morphine as opioid agonist therapy

Recommendations for the use of slow-release oral morphine as opioid agonist therapy

Evidence, Guidelines and Recommendations

Bringing together published evidence and both clinical and experiential expertise, these recommendations are intended to guide prescribers in the use of slow-release oral morphine (SROM, brand name Kadian) as opioid agonist therapy (OAT).

Détails

Catégorie
Evidence, Guidelines and Recommendations
Format
Document PDF
Taille du fichier
Fichier introuvable.
Téléchargements
0
Ajouté
25 août 2025
Tags
Psychiatrie
Douleur
Santé mentale
Troubles liés à l'usage de substances
Soins primaires
Médecine interne
Médecine d’urgence

Ressources connexes

Buprenorphine/Naloxone for Opioid Dependence: Clinical Practice Guideline
The objective of this guideline is to provide clinical recommendations for the initiation, maintenance and discontinuation of buprenorphine/naloxone maintenance treatment in the ambulatory treatment of adults and adolescents with opioid dependence in Ontario.
Health Quality Ontario Standards: Opioid Use Disorder (Opioid Addiction)
This quality standard includes: quality statements, patient reference guide, recommendations for adoption and a getting started guide.
Management of opioid use disorders: a national clinical practice guideline
This guideline was developed to provide Canadian health professionals with an educational tool and clinical practice recommendations for the treatment of opioid use disorder.

En savoir plus

Restez informé

Actualités et mises à jour directement dans votre boîte de réception.

© 2025 McMaster University et autres | 1280, rue Main Ouest | Hamilton, Ontario L8S 4L8 | Conditions d'utilisation